Featured White Papers
Technology Industry
Industry: Email Alert RSS FeedPhilip S. Tabbiner, DBA, has been named CEO of aaiPharma Inc
BT Catalyst, June, 2002
* Philip S. Tabbiner, DBA, has been named CEO of aaiPharma Inc. (Nasdaq: AAII) of Wilmington. In this role, he is responsible for the management of all business operations, including pharmaceuticals, research and development and fee-for-service. Tabbiner succeeds Frederick D. Sancilio, Ph.D., who will become executive chairman and chief scientific officer.
Tabbiner joined aaiPharma in 2000.
COPYRIGHT 2002 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning